The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...

Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

War has devastating consequences on healthcare, with attacks becoming normalised and health weaponised. The scholarship emphasises the longterm human toll, the need for accountability, humanitarian ...

Antimicrobial resistance (AMR) refers to the ability of microbes—bacteria, viruses, fungi and parasites—to survive exposure to drugs that previously cleared them. Mostly, assessments of AMR in ...

In the past, smallpox, polio and measles caused enormous suffering, death and financial health burdens all around the world. However, in recent times, these infectious diseases have been eradicated ...

Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, chronic respiratory disease and mental health. This group of conditions is the leading global cause of morbidity ...

In this commentary, we provide a snapshot of the state of quality improvement (QI) and patient safety in Georgia and introduce the Georgia Health Quality Forum (GHQF), a volunteer initiative to ...

Background Under-five mortality (U5M) is a key indicator and major concern of population health globally, which reflects the quality of maternal and childcare facilities and health services. Despite ...

An interview with the winner of the 2020 BMJ Global Health Grant as well as information on previous winners.

Introduction One of the leading causes of global child mortality continues to be diarrhoea where rotavirus contributed to about 24% of deaths among all diarrhoeal deaths, mostly in low-income and ...

Introduction The United Nations Sustainable Development Goal (UN-SDG) 3.4 aims to reduce premature mortality from non-communicable diseases, including breast cancer, by one-third by 2030 relative to ...

The recently published 2024 WHO Guidance for human genome data collection, access, use and sharing1 introduces a granularity maximisation principle, requiring informed consent to be ‘as granular as ...